v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional paid-in capital
Accumulated other comprehensive loss
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2022     153,990,128        
Beginning balance at Dec. 31, 2022 $ 808,216 $ 941 $ 154 $ 810,186 $ (2,899) $ 775 $ 941
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
RSUs and MSUs vested (in shares)     2,692,984        
RSUs and MSUs vested 3   $ 3        
ESPP purchase (in shares)     273,569        
ESPP purchase 2,306     2,306      
Option exercises (in shares)     641,250        
Option exercises 5,584   $ 1 5,583      
Stock-based compensation 65,311     65,311      
Foreign currency translation adjustment (789)       (789)    
Net income (loss) (2,926)         (2,926)  
Ending balance (in shares) at Sep. 30, 2023     157,597,931        
Ending balance at Sep. 30, 2023 878,646   $ 158 883,386 (3,688) (1,210)  
Beginning balance (in shares) at Jun. 30, 2023     156,279,075        
Beginning balance at Jun. 30, 2023 878,214   $ 156 867,490 (1,971) 12,539  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
RSUs and MSUs vested (in shares)     1,102,702        
RSUs and MSUs vested 1   $ 1        
ESPP purchase (in shares)     162,406        
ESPP purchase 1,424     1,424      
Option exercises (in shares)     53,748        
Option exercises 591   $ 1 590      
Stock-based compensation 13,882     13,882      
Foreign currency translation adjustment (1,717)       (1,717)    
Net income (loss) (13,749)         (13,749)  
Ending balance (in shares) at Sep. 30, 2023     157,597,931        
Ending balance at Sep. 30, 2023 $ 878,646   $ 158 883,386 (3,688) (1,210)  
Beginning balance (in shares) at Dec. 31, 2023 158,757,620   158,757,620        
Beginning balance at Dec. 31, 2023 $ 909,456   $ 159 901,259 (916) 8,954  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
RSUs and MSUs vested (in shares)     2,827,628        
RSUs and MSUs vested 3   $ 3        
ESPP purchase (in shares)     325,854        
ESPP purchase 3,373     3,373      
Option exercises (in shares)     44,049        
Option exercises 313     313      
Stock-based compensation 47,178     47,178      
Foreign currency translation adjustment (360)       (360)    
Net income (loss) $ 22,524         22,524  
Ending balance (in shares) at Sep. 30, 2024 161,955,151   161,955,151        
Ending balance at Sep. 30, 2024 $ 982,487   $ 162 952,123 (1,276) 31,478  
Beginning balance (in shares) at Jun. 30, 2024     160,786,740        
Beginning balance at Jun. 30, 2024 947,576   $ 161 934,194 (2,168) 15,389  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
RSUs and MSUs vested (in shares)     995,796        
RSUs and MSUs vested 1   $ 1        
ESPP purchase (in shares)     172,615        
ESPP purchase 1,478     1,478      
Stock-based compensation 16,451     16,451      
Foreign currency translation adjustment 892       892    
Net income (loss) $ 16,089         16,089  
Ending balance (in shares) at Sep. 30, 2024 161,955,151   161,955,151        
Ending balance at Sep. 30, 2024 $ 982,487   $ 162 $ 952,123 $ (1,276) $ 31,478